Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer
Medical Sciences · 07.04.2024 · 12 (2) · 20
DOI: 10.3390/medsci12020020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 07.04.2024. Verfasst von Morgann Hendrixson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Sorafenib, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIEHS R21.
Abstract (Originalsprache)
Lung cancer remains the leading cause of cancer-related deaths, with a poor prognosis. Of the two types, non-small cell lung cancer (NSCLC) is the major and most prevalent type and associated with low response rates to the current treatment options. Sorafenib, a multitargeted tyrosine kinase inhibitor used for various malignancies, gained attention for its potential efficacy in NSCLC. This review paper focuses on the findings of recent in vitro, in vivo, and clinical studies regarding the efficacy of sorafenib. Overall, sorafenib has shown definitive therapeutic potential in NSCLC cell lines, xenografts, and human subjects. Novel approaches to sorafenib delivery may improve its efficacy and should be the focus of further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA.
- Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA.
ORCID-Profile: Morgann Hendrixson, Ravi P Sahu
Förderung
- NIEHS NIH HHS
- NIEHS R21
Zitieren
APA
Hendrixson, M., Gladkiy, Y., Thyagarajan, A., & Sahu, R. P. (2024). Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical Sciences, 12(2), 20. https://doi.org/10.3390/medsci12020020
Vancouver
Hendrixson M, Gladkiy Y, Thyagarajan A, Sahu RP. Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical Sciences. 2024;12(2):20. doi:10.3390/medsci12020020
BibTeX
@article{Hendrixson2024,
author = {Hendrixson, Morgann and Gladkiy, Yevgeniy and Thyagarajan, Anita and Sahu, Ravi P},
title = {Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer},
journal = {Medical Sciences},
year = {2024},
volume = {12},
number = {2},
pages = {20},
doi = {10.3390/medsci12020020}
}
EUVIMED